U.S. Pharmaceutical Sales - Q4 2013

The following is a list of the top 100 prescribed medicines by US National Sales in Q4 2013. Figures include sales through both retail and hospital channels, listed by drug name and units sold in the United States.

Last updated: February 2014 (updated quarterly).

Top 100 Drugs for Q4 2013 by Units Sold

Rank Drug Units (000)
1 (1) budesonide
Generic
60.65% Stats
2 (1) acetaminophen/hydrocodone
Generic
1.25% Stats
3 ProAir HFA
Teva Pharmaceuticals
9.86% Stats
4 () ONE TOUCH ULTRA
Stats
5 () levothyroxine
Generic
Stats
6 () Ventolin HFA
GlaxoSmithKline
Stats
7 (1) Nexium
AstraZeneca Pharmaceuticals, LP
-2.75% Stats
8 (1) Advair Diskus
GlaxoSmithKline
0.21% Stats
9 (1) Lantus Solostar
Sanofi (formerly Sanofi Aventis)
1.95% Stats
10 (5) Cymbalta
Eli Lilly and Company
-25.41% Stats
11 (2) Lantus
Sanofi (formerly Sanofi Aventis)
-4.37% Stats
12 (1) enoxaparin
Generic
15.55% Stats
13 (1) Crestor
AstraZeneca Pharmaceuticals, LP
1.58% Stats
14 Levemir
Novo Nordisk, Inc.
0.86% Stats
15 (1) metoprolol
Generic
4.77% Stats
16 (3) Spiriva
Boehringer Ingelheim Pharmaceuticals, Inc
-9.61% Stats
17 (2) NovoLog FlexPen
Novo Nordisk, Inc.
1.13% Stats
18 Humalog
Eli Lilly and Company
1.25% Stats
19 Novolog
Novo Nordisk, Inc.
-2.90% Stats
20 (1) Abilify
Otsuka Pharmaceutical Co., Ltd
0.47% Stats
21 (1) Synthroid
Abbott Laboratories
-4.79% Stats
22 Januvia
Merck & Co., Inc.
-2.78% Stats
23 Nasonex
Merck & Co., Inc.
-1.41% Stats
24 Lyrica
Pfizer Inc
1.10% Stats
25 (1) Symbicort
AstraZeneca Pharmaceuticals, LP
7.48% Stats
26 () Tamiflu
Roche Pharmaceuticals
Stats
27 (2) Zetia
Merck & Co., Inc.
-3.33% Stats
28 (1) Namenda
Forest Pharmaceuticals, Inc
-9.12% Stats
29 (4) Flovent HFA
GlaxoSmithKline
7.77% Stats
30 (2) Diovan
Novartis Corporation
-3.65% Stats
31 (2) Suboxone
Reckitt Benckiser Pharmaceuticals Inc.
-3.16% Stats
32 (1) fenofibrate
Generic
3.18% Stats
33 (3) Remicade
Centocor Ortho Biotech, Inc
-4.85% Stats
34 (2) AndroGel
AbbVie, Inc.
-1.76% Stats
35 Restasis
Allergan, Inc
3.60% Stats
36 () lidocaine
Generic
Stats
37 (3) Dexilant
Takeda Pharmaceuticals U.S.A., Inc
-2.27% Stats
38 (2) Benicar
Daiichi Sankyo
-4.10% Stats
39 (2) Lovaza
GlaxoSmithKline
-5.05% Stats
40 (2) Xarelto
Ortho-McNeil-Janssen Pharmaceuticals, Inc.
15.58% Stats
41 (2) Humalog KwikPen
3.91% Stats
42 (2) OxyContin
-1.87% Stats
43 (2) VESIcare
Astellas Pharma US
0.39% Stats
44 (1) Enbrel
Amgen Inc.
-1.14% Stats
45 Celebrex
Pfizer Inc
1.71% Stats
46 (3) Combivent Respimat
11.15% Stats
47 (3) Vytorin
Merck & Co., Inc.
-7.40% Stats
48 Cialis
Eli Lilly and Company
1.99% Stats
49 (2) Janumet
Merck & Co., Inc.
-3.46% Stats
50 Pradaxa
Boehringer Ingelheim Pharmaceuticals, Inc
-3.53% Stats
51 (1) doxycycline
Generic
2.57% Stats
52 (1) methylphenidate
Generic
10.45% Stats
53 (2) Evista
Eli Lilly and Company
-4.55% Stats
54 Vyvanse
Shire US Inc
8.70% Stats
55 amphetamine/dextroamphetamine
Generic
5.27% Stats
56 (1) Humira
AbbVie, Inc.
1.52% Stats
57 (2) Victoza
Novo Nordisk, Inc.
3.73% Stats
58 Epogen
Amgen Inc.
1.12% Stats
59 () divalproex sodium
Generic
Stats
60 (1) Rituxan
Genentech, Inc (member of Roche group)
1.30% Stats
61 (1) Truvada
Gilead Sciences, Inc.
-0.56% Stats
62 (1) Avastin
Genentech, Inc (member of Roche group)
0.22% Stats
63 (3) Atripla
Gilead Sciences, Inc.
-0.23% Stats
64 (3) Viagra
Pfizer Inc
-1.00% Stats
65 (1) Rebif
-12.61% Stats
66 (2) Seroquel XR
AstraZeneca Pharmaceuticals, LP
0.80% Stats
67 (2) Renvela
Genzyme Corporation
11.90% Stats
68 (4) Sensipar
Amgen Inc.
10.78% Stats
69 (2) Orencia
Bristol-Myers Squibb Company
0.31% Stats
70 Neulasta
Amgen Inc.
-6.10% Stats
71 (3) Xolair
-1.68% Stats
72 (1) Lunesta
Sunovion Pharmaceuticals Inc.
-6.58% Stats
73 (4) Adderall XR
Shire US Inc
1.81% Stats
74 (4) Lucentis
Genentech, Inc (member of Roche group)
0.36% Stats
75 (5) Prezista
Janssen Pharmaceuticals, Inc
3.10% Stats
76 (3) Isentress
Merck & Co., Inc.
-0.38% Stats
77 (2) Procrit
Janssen Pharmaceuticals, Inc
-10.00% Stats
78 (4) Reyataz
Bristol-Myers Squibb Company
-2.53% Stats
79 (2) Aranesp
Amgen Inc.
-11.43% Stats
80 (4) Alimta
Eli Lilly and Company
7.94% Stats
81 (2) Copaxone
Teva Pharmaceuticals
-5.16% Stats
82 (7) Zostavax
Merck & Co., Inc.
20.53% Stats
83 (2) Prevnar 13
Wyeth
6.51% Stats
84 (4) Invega Sustenna
Janssen Pharmaceuticals, Inc
9.68% Stats
85 (1) Herceptin
Genentech, Inc (member of Roche group)
3.09% Stats
86 () Synagis
MedImmune, Inc
Stats
87 Neupogen
Amgen Inc.
-5.77% Stats
88 (2) Xgeva
Amgen Inc.
3.08% Stats
89 (2) Betaseron
Bayer Healthcare Pharmaceuticals
-3.33% Stats
90 (2) Tecfidera
Biogen Idec
16.49% Stats
91 () Complera
Gilead Sciences, Inc.
Stats
92 () Stribild
Stats
93 Gleevec
Novartis Corporation
3.85% Stats
94 Avonex
Biogen Idec
-6.67% Stats
95 Gilenya
Novartis Corporation
4.92% Stats
96 Xeloda
Roche Pharmaceuticals
1.69% Stats
97 Avonex Pen
Biogen Idec
8.33% Stats
98 Zytiga
Centocor Ortho Biotech, Inc
5.88% Stats
99 Stelara
11.11% Stats
100 Afinitor
Novartis Corporation
Stats

* Units refer to the number of packages sold.

Source: IMS Health (Midas). Please review our terms of use and attribution guidelines. Copyright - All rights reserved. Unauthorized use and/or duplication of this material without express written permission is strictly prohibited.

Hide
(web3)